Life-threatening adverse drug reaction to paclitaxel. Postmarketing surveillance.
Clin Transl Oncol
; 8(1): 60-1, 2006 Jan.
Article
em En
| MEDLINE
| ID: mdl-16632443
The mechanism of action of hypersensitivity reactions from paclitaxel has not been fully understood. It has not even been defined if they are secondary to paclitaxel, its vehicle or the premedication. Postmarketing pharmacovigilance is predominantly based on spontaneous reporting. These reports albeit biased and incomplete serve to detect previously unrecognised adverse events. We report a life threatening adverse event related to paclitaxel without any evidence of histamine release. It consisted of a cardiac arrest probably secondary to bradiarrhythmia or branch block.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vigilância de Produtos Comercializados
/
Bradicardia
/
Bloqueio de Ramo
/
Paclitaxel
/
Parada Cardíaca
/
Antineoplásicos Fitogênicos
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Screening_studies
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Article